or Try an Advanced Search...

    Technical Analysis for HRMY - Harmony Biosciences Holdings, Inc.

    Grade Last Price % Change Price Change
    F 29.43 -0.91% -0.27
    HRMY closed down 0.54 percent on Wednesday, May 15, 2024, on 67 percent of normal volume.
    Earnings due: May 29
    *** please verify all earnings dates ***
    6 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical HRMY trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish -0.91%
    MACD Bearish Signal Line Cross Bearish -0.91%
    Multiple of Ten Bearish Other -0.91%
    Inside Day Range Contraction -0.91%
    Gapped Up Strength -0.91%
    200 DMA Resistance Bearish -1.44%
    50 DMA Resistance Bearish -1.44%
    Fell Below 20 DMA Bearish -1.44%
    MACD Bearish Centerline Cross Bearish -1.44%
    Expansion Pivot Sell Setup Bearish Swing Setup -1.44%
    Older End-of-Day Signals for HRMY ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 43 minutes ago
    Down 1% about 20 hours ago
    Possible Inside Day about 21 hours ago
    Gap Up Closed about 24 hours ago
    60 Minute Opening Range Breakdown about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    HRMY Chart by TradingView
    Basic chart:

    Profile

    Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Neurological Disorders Stage Pharmaceutical Ethers Urological Disorders Chloroarenes Narcolepsy Piperidines Rare Neurological Disorders Stimulants

    Is HRMY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 4 Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
    May 3 Harmony Biosciences Holdings First Quarter 2024 Earnings: EPS Beats Expectations
    May 2 Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences is a Solid Choice
    May 1 Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice
    May 1 HRMY or TECH: Which Is the Better Value Stock Right Now?
    May 1 Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript
    Apr 30 Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
    Apr 30 Harmony Biosciences: Company's Q1 Update Music To Investor Ears (Upgrade)
    Apr 30 Harmony Biosciences Holdings, Inc (HRMY) Q1 2024 Earnings Call Transcript
    Apr 30 Harmony Biosciences Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation
    See more HRMY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 39.265
    52 Week Low 18.6112
    Average Volume 435,504
    200-Day Moving Average 31.02
    50-Day Moving Average 30.90
    20-Day Moving Average 30.15
    10-Day Moving Average 30.84
    Average True Range 1.33
    RSI (14) 44.44
    ADX 19.11
    +DI 22.49
    -DI 20.58
    Chandelier Exit (Long, 3 ATRs) 30.41
    Chandelier Exit (Short, 3 ATRs) 32.13
    Upper Bollinger Bands 32.10
    Lower Bollinger Band 28.20
    Percent B (%b) 0.38
    BandWidth 12.92
    MACD Line -0.10
    MACD Signal Line -0.09
    MACD Histogram -0.0192
    Fundamentals Value
    Market Cap 1.74 Billion
    Num Shares 58.6 Million
    EPS 2.47
    Price-to-Earnings (P/E) Ratio 12.02
    Price-to-Sales 3.82
    Price-to-Book 4.06
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 31.43
    Resistance 3 (R3) 31.54 31.07 31.14
    Resistance 2 (R2) 31.07 30.63 31.02 31.05
    Resistance 1 (R1) 30.39 30.36 30.15 30.28 30.95
    Pivot Point 29.92 29.92 29.80 29.86 29.92
    Support 1 (S1) 29.23 29.47 29.00 29.12 28.45
    Support 2 (S2) 28.76 29.20 28.71 28.35
    Support 3 (S3) 28.08 28.76 28.26
    Support 4 (S4) 27.97